Search peptides, terms, sources/
Research source · 2025

Probability of achieving bone mineral density treatment targets with abaloparatide and teriparatide

About this source

Kind
Research
Design
Human observational
Population
2,463 women aged 49 to 86 from the ACTIVE trial
Sample size
2463
Primary or secondary
primary
Peer review
peer reviewed
Retraction status
None known
Date checked
14 November 2026

Limitations

Post hoc modelling of bone-density targets from the ACTIVE trial, not a fracture outcome and not a head-to-head test. The authors' conflicts of interest were not read from the abstract record.

Cited in

Spotted an error? Report a problem with this page. We correct the record and log every change on What's changed.